Device interaction between cardiac contractility modulation (CCM) and subcutaneous defibrillator (S-ICD).
CCM
S-ICD
T wave oversensing
crosstalk test
heart failure
interferences
noise
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
31
05
2021
received:
05
03
2021
accepted:
28
07
2021
pubmed:
12
8
2021
medline:
1
12
2021
entrez:
11
8
2021
Statut:
ppublish
Résumé
Combined implantation of cardiac contractility modulation (CCM) with subcutaneous implantable cardioverter-defibrillator (S-ICD) appears a suitable option to reduce the amount of intracardiac leads and complications for patients. Here we report on a patient with ischemic cardiomyopathy carrying an S-ICD in which a CCM device was implanted. During crosstalk testing post-CCM implantation, the S-ICD misannotated QRS complexes and T waves. The problem was solved through reprogramming the CCM, while preserving S-ICD functionality and improving heart failure symptoms. In conclusion, S-ICD combined with CCM seems to be a good and safe option for patients when device interference is being ruled out.
Types de publication
Case Reports
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3095-3098Informations de copyright
© 2021 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.
Références
Abraham WT, Kuck KH, Goldsmith RL, et al. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC. Heart Fail. 2018;6(10):874-883. https://doi.org/10.1016/j.jchf.2018.04.010
Wiegn P, Chan R, Jost C, et al. Safety, performance, and efficacy of cardiac contractility modulation delivered by the 2-lead optimizer smart system: the FIX-HF-5C2 study. Circ Heart Fail. 2020;13(4):e006512. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006512
Priori SG, Blomström-Lundqvist C, Mazzanti A, et al, ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-2867.
Röger S, Rudic B, Akin I, et al. Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction. Clin Cardiol. 2018;41(4):518-524. https://doi.org/10.1002/clc.22919
Kloppe A, Mijic D, Schiedat F, et al. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: a preliminary report. Cardiol J. 2016;23(1):114-119. https://doi.org/10.5603/CJ.a2015.0073